-
A
U2OS cells stably expressing Strep‐HA‐ZAKβ or ‐ZAKα were treated with sorbitol (500 mM, 1 h) as indicated. Cells were fixed, immunostained with HA antibody, and counterstained with DAPI.
-
B
U2OS cells stably expressing ZAKβ‐GFP were treated with sorbitol (500 mM, 1 h), pre‐extracted, fixed, and immunostained with Lamin A/C antibody. Lower right: Intensity distribution graph showing fluorescence intensities along the magenta line.
-
C
As in (B) except that Hela cells were transfected with ZAKbeta‐GFP and immunostained with 53BP1 antibody.
-
D
Cells from (B) were imaged by live‐cell fluorescence microscopy. Sorbitol (final concentration 500 mM) was added after the acquisition of the first frame.
-
E
As in (D), except that cells were co‐transfected with mCherry‐FAK. Inserts show higher magnification of the yellow and red regions, white arrow indicates the direction of stress fibers.
-
F
Schematic of GFP‐tagged ZAKβ truncation constructs.
-
G
U2OS cells were transfected with constructs from (F) and imaged by live‐cell fluorescence microscopy. Sorbitol (final concentration 500 mM) was added after the acquisition of the first frame.
-
H
U2OS and ΔZAK cells stably expressing the indicated Strep‐HA‐tagged ZAKβ constructs were treated with sorbitol (500 mM, 5 min). Lysates were analyzed by immunoblotting with the indicated antibodies.